| 0 (0%) | 12-16 08:39 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 29.72 |
1-year : | 34.71 |
| Resists | First : | 25.45 |
Second : | 29.72 |
| Pivot price | 25.2 |
|||
| Supports | First : | 25.16 |
Second : | 24.98 |
| MAs | MA(5) : | 25.24 |
MA(20) : | 25.19 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 70.9 |
D(3) : | 63.5 |
| RSI | RSI(14): 60.4 |
|||
| 52-week | High : | 25.45 | Low : | 24.89 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CCID ] has closed below upper band by 3.8%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 25.36 - 25.49 | 25.49 - 25.59 |
| Low: | 24.87 - 25.02 | 25.02 - 25.14 |
| Close: | 25.13 - 25.35 | 25.35 - 25.54 |
Mon, 15 Dec 2025
CCID Court officials give wish list to lawmakers. See what they’re asking for - WLBT
Mon, 15 Dec 2025
CCID Court officials give wish list to lawmakers. See what they’re asking for - WLBT
Thu, 11 Dec 2025
Clinical characteristics of granular parakeratosis caused by benzalkon | CCID - Dove Medical Press
Mon, 08 Dec 2025
Hydrolyzed Marine Collagen: Unanticipated Benefits via the Oral Route | CCID - Dove Medical Press
Mon, 01 Dec 2025
CCID Consulting Announces EGM to Approve Governance Amendments - TipRanks
Mon, 10 Nov 2025
CCID: A 7.375% Term Preferred IPO From Carlyle Credit Income Fund (NYSE:CCIF) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 22 (%) |
| Shares Short | 3 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0.15 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|